Real-world effectiveness of zanubrutinib plus salvage chemotherapy in relapsed or refractory double-expressor DLBCL.

Ann Hematol · 2026 · PMC13079505 · PMID 41981343

Europe PMC DOI

hedged sentence

0.1030

closest p · 2.1× alpha

0.1030

boldest claim

The sentences

showed a trendp = 0.103not close (p > 0.1)

In univariate analysis, elevated baseline LDH showed a trend toward shorter PFS (HR, 2.08; 95% CI, 0.86-5.00; p = 0.103).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.